The developments in the healthcare sector coupled with rising disposable income has led to an unprecedented growth of the healthcare expenditure over the years.

The development of pain management centers is another major factor responsible for the proliferation of the neuropathic pain market through the projection period. The fast-developing economies resonate strong growth opportunities for the market players.

By type, the neuropathic pain market is segmented into peripheral neuropathy, entrapment neuropathy, post-traumatic neuropathy, phantom limb pain, post-herpetic neuralgia (PHN), and trigeminal neuralgia.

The rising prevalence of chronic diseases such as diabetes and cancer that triggers neuropathic pain is a major factor responsible for driving the growth of the market.